A genomic phage clone containing a fulllength copy of a functional human gene for ferritin heavy chain has been isolated. The gene consists of four exons spanning approximately 3 kilobases and has been localized to chromosome 11. The functionality of the gene was demonstrated by the fact that both transient transfectants and stable transformants of murine fibroblasts actively transcribe human ferritin heavychain mRNA.
Ferritin is the major iron-storage protein found in all eukaryotic cells. It is a spherical complex of 24 subunits. Human ferritins consist of various combinations of heavy (Mr 21,000) and light (Mr 19,000) chains. These two subunits share extensive sequence homology but are derived from different genes (1, 2) . Ferritin may serve several functions in iron metabolism. A major function may well be to sequester and thus detoxify iron that is taken up by cells but not utilized for metabolic requirements. High iron uptake results in a high fractional delivery of iron to ferritin and low iron uptake results in a high fractional delivery of iron to non-ferritin pools (3) . The level of ferritin itself seems to determine this fractional distribution within the cell. In addition, ferritin iron can also be released for cellular utilization, especially under conditions of iron need. The amount of ferritin in cells is highly regulated; iron leads to a large increase in the synthesis of both heavy and light chains (4) . The relative synthesis of the two chains varies greatly in different tissues, as a function of development and pathological state (5) (6) (7) . Regulation by iron seems to occur at both transcriptional and translational levels (8, 9) , whereas developmental changes seem to occur at the transcriptional level (2) .
Because of ferritin's central role in iron metabolism, understanding the molecular basis for ferritin regulation is essential to an understanding of cellular iron homeostasis. A major step toward this understanding has been taken with the cloning of cDNAs encoding human ferritin heavy and light chains (2, 10, 11) . Analysis of the genes encoding these proteins will extend these studies and allow us to begin to examine regulatory control elements. Genomic cloning of active ferritin genes is somewhat confounded by Southern blot hybridization studies, which show that the genes for each subunit are part of multigene families (1) . In situ hybridization demonstrates ferritin heavy-chain genes on at least eight different chromosomes and light-chain genes on at least three chromosomes (12) (13) (14) . Which of these represent functional genes and which, pseudogenes is unclear. Detection of human ferritin by immunologic techniques in stable rodent-human hybrid cell lines has pointed to chromosomes 11 and 19 as the source of heavy and light chains, respectively (15, 16) . Several genomic clones for ferritin heavy and light chains have been described. Many of these genes appear to be pseudogenes that do not contain introns and that may have arisen by reverse transcription of ferritin mRNA in germ-line cells (17, 18 
MATERIALS AND METHODS
Cloning of a Human Genomic Ferritin Heavy-Chain Gene. Clones for the human ferritin heavy-chain gene were isolated from a previously described total human genomic liver library (19) . Three hundred thousand plaques were screened by plaque hybridization (20) using the 496-base-pair (bp) Pst I 3' fragment and the 308-bp Pst I 5' fragment from the ferritin heavy-chain cDNA clone pHF16 (10) . The fragments were labeled by the random priming method (33) .
Thirty-three positive clones were plaque-purified, and DNA was isolated according to standard procedures (20) . One of the clones, M11, gave rise to two EcoRI fragments, of length 5.2 and 10.6 kilobases (kb), which hybridized to the 5' or 5' and 3' probes of the cDNA, respectively. A 7.2-kb HindIII fragment spanning the entire hybridizing region was isolated and subcloned into the plasmid vector pUC8 (Bethesda Research Laboratories) for further characterization (see Fig. 1 ).
Restriction Fragment Characterization and Sequence Analysis. The recombinant plasmid pUCM11 was amplified in Escherichia coli strain HB101, and plasmid DNA was isolated by an alkaline-lysis protocol (20) . Aliquots (1 ,ug) (20) . For assay of stable transformation, the plasmid pUCM11 was coprecipitated with the herpes simplex virus thymidine kinase gene at a molar ratio of 30:1, and transformants were selected and grown in medium containing hypoxanthine, aminopterin, and thymidine (HAT medium) for 3-4 weeks.
A single-stranded 546-bp "antisense" Sac I fragment (465 bp of the Sac I fragment plus 81 bp of the M13 mpl8 polylinker and primer DNA; Fig. 1 (ICN) for not less than 15 hr. After the membranes were baked for 2 hr at 80°C, prehybridization and hybridization were carried out according to the manufacturer's protocol.
DNA probes were 32P-labeled by random priming, to a specific activity of -3 x 108 cpm/4ug, and 106 cpm/ml was added to the prehybridization solution for overnight incubation. The blots were washed three times in changes of 2x SSC/0.5% NaDodSO4 at room temperature and subsequently 0.1x SSC/0.5% NaDodSO4 at 65°C for 20 min each. (lx SSC is 150 mM NaCl/14 mM sodium citrate.) The blots were subjected to autoradiography with a Lightning Plus screen (DuPont) by incubation at -70°C for 1-5 days.
For chromosomal localization, a panel of 44 different human-rodent cell hybrids was analyzed by Southern blotting. The hybrid cell lines used have been described in detail (24) . As a hybridization probe an upstream genomic fragment was isolated from pUCM11 (see Fig. 1 ). This probe did not cross-hybridize with the DNA of mouse RAG and Chinese hamster E36 cells. The chromosomal assignment was made by statistical discordance analysis according to published methods (25) .
RESULTS
Cloning of a Ferritin Heavy-Chain Gene. A human liver genomic library was screened with a 32P-labeled 3' fragment of the heavy-chain cDNA. This 3' probe covered bases 309 to 804 of the cDNA according to the numbering of Boyd et al. (10) . Thirty-three clones were chosen by plaque hybridization, purified, and partially characterized. One ofthese, M11, was chosen for further characterization based on the following criteria: the phage DNA also hybridized to the 5' cDNA fragment (bases 1-308), but the 5' and 3' coding regions ofthe phage insert could be separated by a restriction enzyme (in this case EcoRI) that does not cut the cDNA, thus suggesting that the clone might contain an intron. This resulted in two EcoRI fragments of 5.2 and 10.6 kb. The 5.2-kb fragment strongly hybridized only to the 5' cDNA probe, whereas the 10.6-kb fragment strongly hybridized to both the 5' and the 3' cDNA probe. The entire coding region is contained within a 7.2-kb HindIII fragment, and this was subcloned in pUC8 for further mapping (Fig. 1) . Restriction fragments of this clone (pUCM11) were subcloned in M13 for sequencing by the dideoxy chain-termination method (see Fig. 1 ). Sequencing demonstrated that this genomic clone contains the cDNA sequence previously reported (11) without a single nucleotide change (Fig. 2) . The gene is organized as four exons and three introns. The major transcription start site is located 24 bases downstream of the first T of the "TATA box" (ref. 27 ; see below). This start site will be referred to as nucleotide + 1 of the predicted mRNA. Intron 1 is about 1.65 kb long and is placed between mRNA bases 331 and 332. Intron 2 is 256 bases long, between bases 478 and 479; intron 3 is 96 bases long, between bases 604 and 605. The entire gene covers about 3 kb. Our sequence differs from that of Costanzo et al. (17) in a few places but is otherwise identical in intron placement and in the putative promoter region. The 3' noncoding region is identical to the published cDNA, including the consensus polyadenylylation signal AATAAA. Our sequencing agrees with that of Boyd et al. (10) and the corrected cDNA sequence reported by Costanzo et al. (17, 28) .
Expression of the Ferritin Heavy-Chain Gene. Examination of the sequence of the ferritin gene suggested that it represented a functional gene. In order to test the functionality of the cloned gene, murine B6 fibroblasts were transformed with the 7.2-kb HindIII fragment. Stable transformants were made by cotransfecting with the herpes thymidine kinase gene and selecting transformants in hypoxanthine/aminopterin/ thymidine (HAT) medium for 4 weeks. RNA prepared from nontransformed B6 cells, ferritin transformants, and human K562 cells was hybridized to the Sac I fragment derived from the 5' end of the gene (see Fig. 1 ). These DNARNA hybrids were subjected to nuclease S1 digestion to establish (i) the presence of human ferritin gene transcripts and (ii) the transcription initiation site. The results (Fig. 3) show that human ferritin mRNA was produced in the genomic The nucleotide sequence was determined by the dideoxy chaintermination method (22) according to the sequencing strategy outlined in Fig. 1 . The major transcription initiation site is marked +1, a minor start site (at +9) is underlined. The TATA box and the polyadenylylation signals are boxed. The presence or absence of the bases underscored with an asterisk could not be determined with certainty. The sequence as displayed was prepared using the DNA-DRAW program (26) on a Dec 10 computer (Digital Equipment, Maynard, MA). The encoded amino acid sequence is shown below the nucleotide sequence.
of the TATA box (Fig. 1) . This fragment therefore lacked coding sequence and was determined not to contain highly repetitive sequences as evaluated by hybridization to total genomic DNA. When total genomic DNA samples from normal individuals were digested with EcoRI or HindIII and analyzed by Southern blot hybridization to a ferritin heavychain cDNA probe, a complex pattern of at least 15 bands was seen (Fig. 4) . In contrast, when the subcloned Pst I fragment was used, only a single band was identified under high-stringency conditions with HindIII (7.2 kb) and with BamHI (4.3 kb) (data not shown), as predicted by restriction mapping of the clone. The genomic EcoRI fragment of 6.3 kb was larger than predicted by the map of the clone. This is probably due to truncation of this fragment by Hae III or Alu I in the construction of the library.
Utilizing this Pst I fragment, we attempted to identify the chromosome containing this gene. This was accomplished by analyzing rodent-human hybrid cell lines whose complement of human chromosomes is well-characterized (24) . No crosshybridization of this probe was seen to either hamster or mouse DNA. Discordance analysis of positive hybridization to HindIII digests of hybrid cell genomic DNA localized this gene to chromosome 11 (Fig. 5) .
DISCUSSION
The cloning and expression of this structural gene for human ferritin will allow us to begin to examine the molecular mechanisms involved in ferritin gene expression and regulation. The critical role that this molecule plays in intracellular iron metabolism underscores the importance of being able to evaluate the regulatory aspects of ferritin gene expression. Human ferritin heavy-chain gene sequences represent a large multigene family dispersed over at least eight different human chromosomes. It has been hypothesized that some of these are processed pseudogenes that have arisen by reverse transcription of mRNA in germ-line cells (17) . It is therefore important to emphasize that the gene we report here has a coding region sequence identical to human ferritin heavychain cDNA sequences reported from several tissue sources (2, 10, 28) (with minor sequence discrepancies likely due to 17-10.6 -5 .7 -tW t.. Fig. 1 and Tjian (30) . A translational control mechanism has been suggested by several authors for the iron effect on ferritin biosynthesis (9, 31, 32) . Interestingly, the ferritin heavychain mRNA contains a relatively long 5' noncoding region of 213 nucleotides. Whether this represents the molecular substrate for translational control is not known. In summary, we have isolated a human genomic DNA clone coding for the entire ferritin heavy-chain mRNA. We have demonstrated the functionality of the cloned gene and were able to localize it on human chromosome 11. M.W.H. gratefully acknowledges a fellowship from the Deutsche Forschungsgemeinschaft. We wish to thank Dr. Krishnamurthy Rao for his helpful advice and Drs. Elena Mattia and Jos van Renswoude for their help in the early phase of the project. These studies were supported by National Institutes of Health Grant AM17775.
